This work is licensed under a Creative Commons Attribution 4.0 International License.
SEQ ID NO: 441 of Patent CN110785183A
General Information
DRACP ID DRACP06724
Peptide Name SEQ ID NO: 441 of Patent CN110785183A
Sequence TLDSALNAASYY
Sequence Length 12
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cancer targeted peptides Immunotherapeutic peptides
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target HLA-A*01
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C57H85N13O21
Absent amino acids CEFGHIKMPQRVW
Common amino acids A
Mass 148477
Pl 3.75
Basic residues 0
Acidic residues 1
Hydrophobic residues 5
Net charge -1
Boman Index -974
Hydrophobicity 9.17
Aliphatic Index 90
Half Life
Mammalian: 7.2 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 2980
Absorbance 280nm 270.91
Polar residues 6
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110785183A
Patent Title Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Lung Cancer, Including Nsclc, Sclc and Other Cancers
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.